LSA
TNXP icon

Leonteq Securities AG’s Tonix Pharmaceuticals TNXP Stock Holding History

Leonteq Securities AG’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.7K Hold
5,700
– – ﹤0.01% 741
2026
Q1 		$78.4K Hold
5,700
– – ﹤0.01% 781
2025
Q4 		$89K Buy
5,700
+5,000
+714% +$92.2K ﹤0.01% 826
2025
Q3 		$16.9K Buy
+700
New +$26K ﹤0.01% 1058

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Leonteq Securities AG's TNXP Position: Q2 2026 in Review

Leonteq Securities AG held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2026 at 5,700 shares worth $72.7K. The position accounts for ﹤0.01% of the portfolio, ranked #741.

Leonteq Securities AG first reported a position in TNXP in Q3 2025 and has held it in 4 quarters since. The position peaked at $89K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Leonteq Securities AG held 5,700 shares of Tonix Pharmaceuticals worth $72.7K as of Q2 2026.
  • Leonteq Securities AG left its Tonix Pharmaceuticals share count unchanged in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #741 holding.
  • Leonteq Securities AG first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Leonteq Securities AG's Tonix Pharmaceuticals position peaked at $89K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.